FULTON MARKET — A developer’s plan for a 19-story life science building could join an emerging biotech scene in Fulton Market.
Mark Goodman & Associates Inc. is set to unveil plans for a 500,000-square-foot building on the northwestern edge of the neighborhood at 400 N. Elizabeth St., according to a zoning application filed in May.
The developer will detail plans during a virtual community meeting on Zoom at 6 p.m. Tuesday. Attendees can register here. The meeting is being hosted by Ald. Walter Burnett Jr. (27th) and the West Loop Community Organization.
The building will include over 480,000 square feet of life science and commercial office space. The building also will include 13,422 square feet of open space, 210 parking spaces and 40 bicycle parking spaces, according to the zoning application.
Solomon Cordwell Buenz has been tapped to design the proposed building that is located between the Metra tracks.
The project is the latest life science building pitched by developers.
In May, Mayor Lori Lightfoot and Ald. Walter Burnett Jr. (27th) cut the ribbon on Portal Innovation’s Fulton Labs, a life science and biotech incubator, at 1375 W. Fulton Market St.
Trammell Crow Company is currently building a 16-story building a few blocks away at 400 N. Aberdeen St.
The project proposed by Mark Goodman & Associates Inc. will need approval from Burnett before going before the Plan Commission and Committee on Zoning.
Subscribe to Block Club Chicago, an independent, 501(c)(3), journalist-run newsroom. Every dime we make funds reporting from Chicago’s neighborhoods.
Listen to “It’s All Good: A Block Club Chicago Podcast” here: